Doctor Who is on its most uneven footing in 20 years: what’s next for the beloved series?

The *Doctor Who* franchise, one of the longest-running and most iconic science fiction series in television history, finds itself at a crossroads. For the first time in over two decades, the show is experiencing significant uncertainty, marked by a series of high-profile departures and strategic shifts. At the heart of this turmoil is the current state of the show's production, with the Doctor and the TARDIS seemingly stuck in a kind of liminal space—neither fully active nor entirely dormant. This situation has sparked widespread speculation about the future direction of the series, both creatively and logistically.

The latest developments stem from a string of changes within the show’s structure and leadership. Showrunner Russell T. Davies, whose visionary work in reviving *Doctor Who* in 2005 proved instrumental in re-establishing the series' popularity, has announced his retirement from the project. His tenure, which spanned from 2005 to 2010 and again from 2022 to 2025, saw the show regain its status as a cultural phenomenon, particularly during his second stint, which included a partnership with Disney. Alongside Davies, the production company Bad Wolf, founded in 2015 by former BBC executives, has also stepped back from involvement. Bad Wolf played a crucial role in the 2005 revival, and its departure marks a symbolic shift in the show's production landscape.

Perhaps the most immediate and visible change is the exit of lead actor Ncuti Gatwa, who portrayed the Twelfth Doctor in the show's recent iterations. Gatwa’s tenure lasted just two seasons, making it the shortest run of the Doctor since the brief stint of Christopher Eccleston as the Ninth Doctor. His departure leaves the series without a confirmed successor, further complicating plans for the upcoming season.

The decision to cancel the 2026 Christmas special and delay the start of a new series reflects the broader instability surrounding the show. The BBC, while committed to continuing the series, faces the challenge of finding a new co-production partner, showrunner, and leading actor. These decisions come amid ongoing debates about the show's financial model, distribution strategy, and creative direction.

Historically, *Doctor Who* has enjoyed periods of both triumph and turmoil. Originally launched in 1963, the series faced cancellation in 1989 due to declining viewership and internal conflicts. Its 2005 revival, led by Davies, revitalized the franchise, drawing in a new generation of fans and securing its place in pop culture. However, the show has not always maintained consistent quality, with varying levels of success across different eras. The recent decline in ratings and the challenges posed by the Disney partnership have added to the sense of uncertainty.

The collaboration with Disney, which began in 2022, introduced a new level of investment into the series, with each episode costing approximately $10 million—a stark contrast to the previous BBC budget of $2.5 million. While this funding allowed for more ambitious storytelling and visual effects, it also shifted the show’s accessibility, particularly in international markets. In Australia, for example, *Doctor Who* was no longer available on free-to-air channels but required subscription access via Disney+. Despite these efforts, Disney reportedly deemed the show a commercial failure, leading to the termination of the co-production agreement.

The impact of this partnership extended beyond financial considerations. The show’s production moved away from traditional free-to-air broadcasting, altering how fans engaged with the content globally. Additionally, the delayed release of the spin-off *The War Between the Land and the Sea* highlighted issues with the coordination between the BBC and Disney, further straining their working relationship.

Meanwhile, the continued production of *Doctor Who* in Wales remains a point of pride for the region. Since the show's revival, it has contributed significantly to the local economy, generating over £134 million ($256 million) in revenue from 2004 to 2021. Beyond economic benefits, the show has helped shape the creative industries in Wales, influencing other productions such as *Torchwood* and *The Sarah Jane Adventures*. The use of Welsh locations and landmarks has also fostered a unique identity for the series, reinforcing its connection to the region.

As the search for a new showrunner and production partner continues, the future of *Doctor Who* hangs in the balance. Fans remain hopeful that the series can recover from its current challenges, but the path forward will require careful navigation of logistical, creative, and financial hurdles. With so much at stake, the coming months will likely determine whether *Doctor Who* can reclaim its position as a cornerstone of British television—or if it will continue to drift toward obscurity.